Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Valeant Internat Barbados SrlfiledCriticalValeant Internat Barbados Srl
Priority to MYPI20060143ApriorityCriticalpatent/MY145995A/en
Publication of MY145995ApublicationCriticalpatent/MY145995A/en
A MODIFIED-RELEASE TABLET OF BUPROPION HYDROCHLORIDE COMPRISING (I) A CORE COMPRISING AN EFFECTIVE AMOUNT OF BUPROPION HYDROCHLORIDE, A BINDER, A LUBRICANT; AND (II) A CONTROL RELEASING COAT SURROUNDING SAID CORE; AND (III) A MOISTURE BARRIER SURROUNDING SAID CONTROL RELEASING COAT, WHEREIN THE MODIFIED-RELEASE TABLET IS BIOEQUIVALENT TO WELLBUTRIN® OR ZYBAN®/WELLBUTRIN®SR TABLETS.
MYPI20060143A2006-01-122006-01-12Modified-release tablet of bupropion hydrochloride
MY145995A
(en)
A tetracycline compound, a pharmaceutical composition comprising the tetracycline compound, and the tetracycline compound or the pharmaceutical composition for treating a tetracycline responsive state
Use of a partially neutralized, anionic (meth)acrylate copolymer as a coating for the production of a medicament releasing active substance at reduced ph values
Compounds derived from heterocycles; its preparation process; fungicidal composition comprising said compounds; and method to combat or control phytopathogenic fungi.